News

Now through November 22, CVS/pharmacy customers will have the opportunity to support Stand Up To Cancer (SU2C) at the register in stores nationwide and online at www.cvs.com/SU2C. SU2C

Galecto’s TD139 is currently in Phase I development and is designed to treat idiopathic pulmonary fibrosis (IPF) and other pulmonary fibrotic conditions. TD139 is a highly potent, specific

As part of the deal, AstraZeneca agreed to pay Almirall about $875m of initial consideration, and up to $1.22bn in development, launch and sales-related milestones. The acquisition gives

Dihon’s OTC product portfolio includes Kang Wang indicated to treat dandruff and other scalp disorders, and Pi Kang Wang, an antifungal cream, as well as TCM product Dan

At the time of data cutoff, a total of 41 patients were enrolled with tumor types including NSCLC, head and neck, small cell lung, colorectal and breast cancers,.

Elocta is the trade name of rFVIIIFc in Europe and is also called as Eloctate in the US, Canada, and Australia, where it is approved to treat hemophilia

The FDA committee voted nine to one to recommend approval of once-daily Savaysa 60mg dosing regimen for the reduction in risk of stroke and systemic embolic events (SEE)

The early termination of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions.

AVP-825 is an investigational drug-device combination product developed by OptiNose which uses OptiNose’s patented Bi-Directional Breath Powered technology to deliver a low dose of sumatriptan powder into the